These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19822280)

  • 1. Current status of screening for malignant pleural mesothelioma.
    Pass HI; Carbone M
    Semin Thorac Cardiovasc Surg; 2009; 21(2):97-104. PubMed ID: 19822280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum biomarkers in patients with mesothelioma and pleural plaques and healthy subjects exposed to naturally occurring asbestos.
    Bayram M; Dongel I; Akbaş A; Benli I; Akkoyunlu ME; Bakan ND
    Lung; 2014 Feb; 192(1):197-203. PubMed ID: 24170217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study.
    Park EK; Sandrini A; Yates DH; Creaney J; Robinson BW; Thomas PS; Johnson AR
    Am J Respir Crit Care Med; 2008 Oct; 178(8):832-7. PubMed ID: 18583574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study.
    Roe OD; Creaney J; Lundgren S; Larsson E; Sandeck H; Boffetta P; Nilsen TI; Robinson B; Kjaerheim K
    Lung Cancer; 2008 Aug; 61(2):235-43. PubMed ID: 18281122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of mesothelin and osteopontin levels over time in formerly asbestos-exposed power industry workers.
    Felten MK; Khatab K; Knoll L; Schettgen T; Müller-Berndorff H; Kraus T
    Int Arch Occup Environ Health; 2014 Feb; 87(2):195-204. PubMed ID: 23423281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma.
    Creaney J; Yeoman D; Demelker Y; Segal A; Musk AW; Skates SJ; Robinson BW
    J Thorac Oncol; 2008 Aug; 3(8):851-7. PubMed ID: 18670302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study.
    Hollevoet K; Van Cleemput J; Thimpont J; De Vuyst P; Bosquée L; Nackaerts K; Germonpré P; Vansteelandt S; Kishi Y; Delanghe JR; van Meerbeeck JP
    J Thorac Oncol; 2011 May; 6(5):889-95. PubMed ID: 21358346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of serum mesothelin in an asbestos-exposed population in the Czech Republic.
    Jakubec P; Pelclova D; Smolkova P; Kolek V; Nakladalova M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):472-9. PubMed ID: 24781044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular tumor markers for asbestos-related mesothelioma: serum diagnostic markers.
    Maeda M; Hino O
    Pathol Int; 2006 Nov; 56(11):649-54. PubMed ID: 17040286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asbestos-related disease: screening and diagnosis.
    Rodríguez Portal JA
    Adv Clin Chem; 2012; 57():163-85. PubMed ID: 22870590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood tests for asbestos-related mesothelioma.
    Maeda M; Hino O
    Oncology; 2006; 71(1-2):26-31. PubMed ID: 17344668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.
    Demir M; Kaya H; Taylan M; Ekinci A; Yılmaz S; Teke F; Sezgi C; Tanrikulu AC; Meteroglu F; Senyigit A
    Lung; 2016 Jun; 194(3):409-17. PubMed ID: 27032653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment.
    Grigoriu BD; Scherpereel A; Devos P; Chahine B; Letourneux M; Lebailly P; Grégoire M; Porte H; Copin MC; Lassalle P
    Clin Cancer Res; 2007 May; 13(10):2928-35. PubMed ID: 17504993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble mesothelin-related protein--a blood test for mesothelioma.
    Robinson BW; Creaney J; Lake R; Nowak A; Musk AW; de Klerk N; Winzell P; Hellstrom KE; Hellstrom I
    Lung Cancer; 2005 Jul; 49 Suppl 1():S109-11. PubMed ID: 15950789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein.
    Creaney J; Robinson BW
    Hematol Oncol Clin North Am; 2005 Dec; 19(6):1025-40, v. PubMed ID: 16325121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).
    Fasola G; Belvedere O; Aita M; Zanin T; Follador A; Cassetti P; Meduri S; De Pangher V; Pignata G; Rosolen V; Barbone F; Grossi F
    Oncologist; 2007 Oct; 12(10):1215-24. PubMed ID: 17962615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma.
    Creaney J; Olsen NJ; Brims F; Dick IM; Musk AW; de Klerk NH; Skates SJ; Robinson BW
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2238-46. PubMed ID: 20651076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure.
    Roberts HC; Patsios DA; Paul NS; DePerrot M; Teel W; Bayanati H; Shepherd F; Johnston MR
    J Thorac Oncol; 2009 May; 4(5):620-8. PubMed ID: 19357540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.
    Napolitano A; Antoine DJ; Pellegrini L; Baumann F; Pagano I; Pastorino S; Goparaju CM; Prokrym K; Canino C; Pass HI; Carbone M; Yang H
    Clin Cancer Res; 2016 Jun; 22(12):3087-96. PubMed ID: 26733616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
    Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
    J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.